Table II.
Uretal stone and stent characteristics in the treatment and control groups.
| Authors, year | Mean stone sizes, T/C (mm) | Stone location, T/C(%) | Stent indications, T/C(%) | Stent type | (Ref) |
|---|---|---|---|---|---|
| Dellis et al, 2014 | <10/<10 | LFU (54/48), RU (46/52) | ESWL (78/72), URS (22/28) | Percuflexplus, 6Frx24 or 6Frx26 | (13) |
| Shalaby et al, 2013 | NA | NA | URS/URL (69.5/69.1), PCNL (12.2/8.6), ESWL (17.1/19.8), EDL (1.2/2.5) | Polyurethane | (15) |
| Deliveliotis et al, 2006 | 7.6/7.1 | UU (18/20), MU (22/24), LU (60/56) | SEC, ESWL, URS | Polyurethane, size 5/26 or 5/28 | (16) |
| Damiano et al, 2008 | NA | NA | URS | Polyurethane, 7Fr | (22) |
| Beddingfield et al, 2009 | 6.35/7.21 | Ureteral and/or intrarenal | Ureteral and/or intrarenal urolithiasis | NA | (23) |
| Park et al, 2009 | NA | RU (40/41.7) LFU (60/58.3) | URS, PCNL, LPP, endoureterotomy | Polyurethane, 6Fr | (24) |
| Wang et al, 2009 | 9.0/9.4 | UU (10.1/10.7), MU (31.6/32), LU (58.2/57.3) | URS | Silicone coated, 7Fr | (25) |
| Lee et al, 2010 | 7.27/7.17 | UU (13.3/11.1), MU (26.7/27.8), LU (60/61.1) | URS | Percuflex, 6Fr | (26) |
| Navanimitkul et al, 2010 | NA | NA | URS (19/57.1), PCNL (42.9/19), Balloon dilatation (14.3/23.8) | Polyurethane, 6Fr | (27) |
| Mokhtari et al, 2011 | >10 but <15/>10 but <15 | NA | URS | Rosch, 4.8Fr | (28) |
| Elnashar et al, 2011 | NA | UU (37.7/70.1), LU (62.3/29.9) | URS | 6Frx26 | (29) |
| Nazim et al, 2012 | NA | UU (56.9/38.5), MU (18.5/24.6), LU (24.6/36.9) | URS | Polyurethane, 6Fr or 4.7Fr | (30) |
| Kuyumcuoglu et al, 2012 | 8.0/8.3 | NA | ESWL, URS | Polyurethane, 4.7Frx26 or 4.7Frx28 | (31) |
| Tehranchi et al, 2013 | 9.87/10.41 | UU (17.4/16.7), MU (17.4/8.3), LU (47.8/62.5), IR (17.4/12.5) | URS (82.6/87.5), PCNL (17.4/12.5) | 4.8 Frx28 | (32) |
ESWL, extracorporeal shock wave lithotripsy; PCNL, percutaneous nephrolithotomy; URS, ureteroscopy or ureteroscopy lithotripsy; URL, ureterolithotomy; SEC, spontaneous expulsion of the calculus; EDL, endopyelotomy; LPP, laparoscopicpyeloplasty; UU, upper ureter; MU, middle ureter; LU, lower ureter; RU, right ureter; LFU, left ureter; IR, intrarenal; T, treatment group; C, control group; NA, not available.